ARCHIVES

FDA Accepts DCT Board’s Criteria For Approval Of New Drugs, Explains Plan for Early Action

This article is from The Cancer Letter archive.

Vol. 15 No. 07 | February 17, 1989

Download PDF Visit The Full Archive

Related Articles

FDA Approves New Drug for Advanced Kidney Cancer

May 25, 2007

Broder Says No Thanks To Acknowledgement For Paper’s Title

June 6, 1997

In Brief: Ashworth Named Center Director at UCSF

March 21, 2014

FDA Adopts Plan For Drug Approval After Phase 2; Chabner Unconvinced

November 4, 1988

Colorado Center Delays New Core Grant Application

July 13, 1979

Clinical Center, NCI, NHLBI, Form Center For Interventional Oncology

April 24, 2009